| Basics |
Insulet Corporation
Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
|
| IPO Date: |
May 15, 2007 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$20.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.69 | 1.90%
|
| Avg Daily Range (30 D): |
$2.88 | 0.96%
|
| Avg Daily Range (90 D): |
$3.72 | 1.35%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.46M |
| Avg Daily Volume (30 D): |
.54M |
| Avg Daily Volume (90 D): |
.63M |
| Trade Size |
| Avg Trade Size (Sh.): |
70 |
| Avg Trade Size (Sh.) (30 D): |
33 |
| Avg Trade Size (Sh.) (90 D): |
32 |
| Institutional Trades |
| Total Inst.Trades: |
9,826 |
| Avg Inst. Trade: |
$5.66M |
| Avg Inst. Trade (30 D): |
$18.76M |
| Avg Inst. Trade (90 D): |
$17.41M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.9M |
| Avg Closing Trade (30 D): |
$33.93M |
| Avg Closing Trade (90 D): |
$33.28M |
| Avg Closing Volume: |
55.47K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$.5
|
$1.11
|
|
Diluted EPS
|
|
$.5
|
$1.08
|
|
Revenue
|
$
|
$ 569M
|
$ 543.9M
|
|
Gross Profit
|
$
|
$ 409M
|
$ 377.1M
|
|
Net Income / Loss
|
$
|
$ 35.4M
|
$ 77.5M
|
|
Operating Income / Loss
|
$
|
$ 88.8M
|
$ 88.1M
|
|
Cost of Revenue
|
$
|
$ 160M
|
$ 166.8M
|
|
Net Cash Flow
|
$
|
$ 329.7M
|
$ 81.6M
|
|
PE Ratio
|
|
|
|
|
|
|
